Good Health, Inc. Recalls Vialipro Sex Enhancement Product

On July 16, 2010, the FDA announced that Good Health, Inc. initiated a voluntary recall of ten lots of its dietary supplement Vialipro. An FDA laboratory analysis revealed that the product contained Sulfoaildenafil, which is an analogue of Silenafil. The FDA approved the ingredient for use in male erectile dysfunction drugs. Vialipro does not list Sulfoaildenafil on its label, making the supplement an unapproved drug, an FDA Safety Report article says.

The undeclared ingredient can be dangerous for consumers due to potential interactions with some prescription drugs that can lead to extremely low blood pressure. Those with diabetes, high cholesterol and blood pressure, or a history of heart disease are often prescribed drugs containing nitroglycerin that can lead to adverse side effects when combined with Sulfoaildenafil, the article reports.

Good Health Inc. reports that it “takes this recall very seriously and is committed to the diligent work required to ensuring its products remain free of any potentially unapproved chemicals,” the release states.

The FDA advises all distributors of Vialipro to cease selling the product and to contact Good Health Inc. for further information on the recall. Customers are encouraged to stop using the product and to return all unused portions of it to Good Health Inc. for a refund.

Consumers and health care professionals are urged to report adverse side effects or illnesses related to using Vialipro to the FDA and Good Health Inc. directly.

References:

Hash, Kitty. (July 16, 2010) “Good Health, Inc. Issues a Nationwide Voluntary Recall of Product Marketed as Dietary Supplement” Retrieved on August 26, 2010 from the FDA web site.